Publications
134
Citations
5,581
Est. group size
~2
Recurring co-author estimate
Active years
37
Publishing since 1989
Typically publishes in teams of ~16 · 4% small-team papers (≤3 authors) · across 17 venues
- Interim Results of a "First-in-Human" Phase 1 Clinical Study of Intracerebroventricular Injections of Ex Vivo Expanded, Autologous, Wnt-Activated, Adipose-Derived Stem Cells in Participants with Mild to Moderate Alzheimer's Disease
Cytotherapy · 2025
- Higher BMI is Associated With Improved Survival but Greater Fatigue and Dyspnea: A Pulmonary Fibrosis Foundation Registry Study
American Journal of Respiratory and Critical Care Medicine · 2025
- Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study
The Lancet Haematology · 2025
- Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell–depleted hematopoietic cell transplantation in pediatric and young adult patients
Cytotherapy · 2024
- Late-Onset Noninfectious Pulmonary Complications after Hematopoietic Stem Cell Transplantation
Transplantation and Cellular Therapy · 2024
- DRUG PATTERNS, CLINICAL OUTCOMES, AND ECONOMIC COSTS AMONG HEREDITARY ANGIOEDEMA PATIENTS INITIATING LONG-TERM PROPHYLAXIS
Annals of Allergy Asthma & Immunology · 2024
- Establishing a Graft-Versus-Host Disease (GVHD)-Focused Multidisciplinary Telehealth Clinic
Transplantation and Cellular Therapy · 2024
- Donor‐specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report
British Journal of Haematology · 2024
- Persistent or New Cytopenias Predict Relapse Better than Routine Bone Marrow Aspirate Evaluations After Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome in Children and Young Adult Patients
Transplantation and Cellular Therapy · 2024
- Phase 2 Trial of Ruxolitinib Cream for Chronic Cutaneous GvHD
Transplantation and Cellular Therapy · 2024
- Predictors for Recent Thymic Emigrant T Cell Reconstitution after Hematopoietic Cell Transplantation
Transplantation and Cellular Therapy · 2024
- A Focused Multidisciplinary Telehealth Clinic Increased Patient Access and Significantly Reduced Distress in Patients with Gvhd.
Transplantation and Cellular Therapy · 2024
- Model-Based Dosing of Anti-Thymocyte Globulin in Pediatric Allogeneic Hematopoietic Cell Transplantation Improves Survival Chances: Updated Results from the Single Arm Phase II Parachute-Trial Combined with Real-World Data
Transplantation and Cellular Therapy · 2024
- Phase II Study of Pharmacokinetic Model-Based ATG Dosing to Improve Survival through Enhanced Immune Reconstitution in Pediatric and Adult Patients Undergoing Ex Vivo CD34-Selected Allogeneic HCT (PRAISE-IR)
Transplantation and Cellular Therapy · 2024
- Regulatory T Cell Reconstitution Is Associated with Acute Graft-Versus-Host Disease in Pediatric and Young Adult Hematopoietic Cell Transplant Recipients
Transplantation and Cellular Therapy · 2024
- Transplantation and Cellular Therapy×19
- Blood×16
- Biology of Blood and Marrow Transplantation×8
- Blood Advances×4
- Journal of Clinical Oncology×3
- Tracey Churay
Medicine · University of Michigan
- John E. Levine
Medicine · University of Michigan
- Patrick Elder
Medicine · The Ohio State University
- Jennifer E. Schwartz
Medicine · Indiana University
- Hannah Choe
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile